LBT has potential but FDA approvals are way overhyped until you can demonstrate sales ability. I'd be more excited to hear about more sales in Aus or Europe rather than this announcement.
Everyone thinks healthcare stocks are about having strong evidence and regulatory approvals but in most cases, your ability to sell and get traction is what counts... IMHO.
I was surprised at the massive jump today.
Ann: APAS Independence Receives US FDA 510(k) Clearance, page-117
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.002(14.3%) |
Mkt cap ! $25.04M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.6¢ | 1.5¢ | $2.946K | 185.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 716666 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 4125552 | 4 |
View Market Depth
| Last trade - 14.20pm 19/07/2024 (20 minute delay) ? |
| LBT (ASX) Chart |